Latest Advancements in Radiotherapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 47
Special Issue Editor
Interests: nanoparticles; radiation; radiotherapy; radiology; dose; radio-sensitization; ionizing radiations; theranostic; radiobiology; non-ionizing radiation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiotherapy is normally a treatment method for more than 60% of cancer patients, alongside either surgery or chemotherapy or in combination. This common cancer treatment procedure is based on technological and radiobiological advancements.
This Special Issue will comprise research outputs of both the latest technological developments and/or physics-based studies of radiotherapy, such as dosimetry. Additionally, it will include research studies based on radiobiological advancements.
Another aspect of this Special Issue will be its inclusion of studies employing nanotechnology to improve the quality and efficiency of radiotherapy. This could involve the application of nanoparticles to enhance radiotherapy doses delivered to tumors. Moreover, this Special Issue will also accept research works investigating the latest radiotherapy advancements, such as FLASH beams and studies investigating various beams employed in radiotherapy.
Dr. Moshi Geso
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiobiology
- dosimetry
- nanoparticles
- FLASH
- radiation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
